You are here
Miromatrix Medical Inc.
UEI: FRFCJNBVB911
# of Employees: 32
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Perfusion decellularization and recellularization for the creation of a bioengineered transplantable liver
Amount: $1,997,489.00ABSTRACT Liver transplantation currently represents the only treatment for end stage liver disease (ESLD), the 8th most frequent cause of death in the United States (US). Efforts to overcome the chron ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
SBIR Phase II: A Perfusable, Revascularized, Cardiac-Derived Patch for the Treatment of Heart Disease
Amount: $500,000.00This Small Business Innovations Research Phase (SBIR) II project is to support the continued development of using proprietary perfusion decellularization technology to create a fully revascularized ca ...
SBIRPhase II2013National Science Foundation -
SBIR Phase I: A Perfusable, Revascularized, Cardiac-Derived Patch for the Treatment of Heart Disease
Amount: $150,000.00This Small Business Innovations Research (SBIR) Phase I proposal is to demonstrate the feasibility of using Miromatrix' perfusion decellularization technology to create a fully revascularized car ...
SBIRPhase I2012National Science Foundation